Thanks for emailing that article!
The Steven and Michele Kirsch Catalyst for a Cure Vision Restoration Initiative is exploring and developing novel strategies to protect, repair, and replace lost retinal nerve cells and help them reconnect with the visual brain.
The eye focuses light onto a tissue in the back of the eyeball called the retina. There are about a million optic nerve cells lining the retina. Each optic nerve cell has a long fiber that connects a point on the retina to a corresponding point on the brain. The optic nerve is a collection of about a million of these fibers. Light information is processed by the retina and then transmitted via the optic nerve to the brain where we experience vision.
In glaucoma there is damage to the optic nerve head, often caused by increased pressure inside the eye, which leads to degeneration of the fiber of the optic nerve cell, and eventually, death of the optic nerve cell. Once those optic nerve cells die, that point on the retina is no longer connected to the brain, and that disconnected area forms a visual field defect. As the disease progresses, more and more nerve cells become disconnected, leading to vision loss.
Current glaucoma treatments focus on preserving vision, but we have no current treatments to restore vision. The Catalyst for a Cure researchers are pursuing two major goals that are both necessary for vision restoration:
Transplanted optic nerve cells need to survive, to regenerate, and to connect to the correct area of the brain in order for vision to be restored.
Last reviewed on July 30, 2021
This article appeared in the May 2021 issue of Gleams.Subscribe